[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100053390":3},{"organization":4,"armGroups":7,"interventions":39,"overallOfficials":11,"centralContacts":69,"locations":75,"responsibleParty":354,"collaborators":356,"id":359,"slug":11,"hasResults":360,"nctId":361,"briefTitle":362,"officialTitle":363,"acronym":11,"eligibilityCriteria":364,"healthyVolunteers":360,"sex":365,"minAge":366,"maxAge":11,"enrollmentInfo":367,"targetDuration":11,"studyType":370,"phases":371,"briefSummary":373,"conditions":374,"keywords":378,"overallStatus":78,"whyStopped":11,"lastUpdateSubmitDate":383,"lastUpdatePostDateStruct":384,"startDateStruct":387,"completionDateStruct":389,"leadSponsor":391,"locationsCount":392},{"fullName":5,"class":6},"R1 Therapeutics","INDUSTRY",[8,14,18,22,26,30,34],{"label":9,"type":10,"description":11,"interventionNames":12},"Cohort 1","EXPERIMENTAL",null,[13],"Drug: AP306 75 mg BID",{"label":15,"type":10,"description":11,"interventionNames":16},"Cohort 2",[17],"Drug: AP306 125 mg BID",{"label":19,"type":10,"description":11,"interventionNames":20},"Cohort 3",[21],"Drug: AP306 150 mg BID",{"label":23,"type":10,"description":11,"interventionNames":24},"Cohort 4",[25],"Drug: AP306 75 mg TID",{"label":27,"type":10,"description":11,"interventionNames":28},"Cohort 5",[29],"Drug: AP306 100 mg TID",{"label":31,"type":10,"description":11,"interventionNames":32},"Cohort 6",[33],"Drug: AP306 125 mg TID",{"label":35,"type":36,"description":11,"interventionNames":37},"Cohort 7","PLACEBO_COMPARATOR",[38],"Drug: Placebo",[40,45,49,53,57,61,65],{"type":41,"name":42,"description":43,"armGroupLabels":44,"otherNames":11},"DRUG","AP306 75 mg BID","AP306 75 mg by mouth, twice daily (150 mg\u002Fday). Placebo given once daily. Treatment given daily for 8 weeks.",[9],{"type":41,"name":46,"description":47,"armGroupLabels":48,"otherNames":11},"AP306 125 mg BID","AP306 125 mg by mouth, twice daily (250 mg\u002Fday). Placebo given once daily. Treatment given daily for 8 weeks.",[15],{"type":41,"name":50,"description":51,"armGroupLabels":52,"otherNames":11},"AP306 150 mg BID","AP306 150 mg by mouth, twice daily (300 mg\u002Fday). Placebo given once daily. Treatment given daily for 8 weeks.",[19],{"type":41,"name":54,"description":55,"armGroupLabels":56,"otherNames":11},"AP306 75 mg TID","AP306 75 mg by mouth, three times daily (225 mg\u002Fday). Treatment given daily for 8 weeks.",[23],{"type":41,"name":58,"description":59,"armGroupLabels":60,"otherNames":11},"AP306 100 mg TID","AP306 100 mg by mouth, three times daily (300 mg\u002Fday). Treatment given daily for 8 weeks.",[27],{"type":41,"name":62,"description":63,"armGroupLabels":64,"otherNames":11},"AP306 125 mg TID","AP306 125 mg by mouth, three times daily (375 mg\u002Fday). Treatment given daily for 8 weeks.",[31],{"type":41,"name":66,"description":67,"armGroupLabels":68,"otherNames":11},"Placebo","Placebo given by mouth, three times daily. Treatment given daily for 8 weeks.",[35],[70],{"name":71,"role":72,"phone":73,"phoneExt":11,"email":74},"Clinical Trials Information","CONTACT","(844) 697-3339","ClinicalTrials@r1therapeutics.com",[76,89,99,108,118,128,138,147,157,167,177,187,197,206,215,224,234,244,252,261,268,274,280,288,298,308,313,322,331,336,345],{"facility":77,"status":78,"city":79,"state":80,"zip":81,"country":82,"cosmosGeoPoint":83,"geoPoint":88,"contacts":11},"Apogee Clinical Research, LLC","RECRUITING","Huntsville","Alabama","35801","United States",{"type":84,"coordinates":85},"Point",[86,87],-86.58594,34.7304,{"lat":87,"lon":86},{"facility":90,"status":78,"city":91,"state":92,"zip":93,"country":82,"cosmosGeoPoint":94,"geoPoint":98,"contacts":11},"California Institute of Renal Research","Chula Vista","California","91910",{"type":84,"coordinates":95},[96,97],-117.0842,32.64005,{"lat":97,"lon":96},{"facility":100,"status":78,"city":101,"state":92,"zip":102,"country":82,"cosmosGeoPoint":103,"geoPoint":107,"contacts":11},"Academic Medical Research Institute","Los Angeles","90022",{"type":84,"coordinates":104},[105,106],-118.24368,34.05223,{"lat":106,"lon":105},{"facility":109,"status":110,"city":111,"state":92,"zip":112,"country":82,"cosmosGeoPoint":113,"geoPoint":117,"contacts":11},"R1 Therapeutics Clinical Trial Site","NOT_YET_RECRUITING","San Dimas","91773",{"type":84,"coordinates":114},[115,116],-117.80673,34.10668,{"lat":116,"lon":115},{"facility":119,"status":78,"city":120,"state":121,"zip":122,"country":82,"cosmosGeoPoint":123,"geoPoint":127,"contacts":11},"Colorado Kidney Care","Denver","Colorado","80220",{"type":84,"coordinates":124},[125,126],-104.9847,39.73915,{"lat":126,"lon":125},{"facility":129,"status":78,"city":130,"state":131,"zip":132,"country":82,"cosmosGeoPoint":133,"geoPoint":137,"contacts":11},"DaVita Clinical Research","Middlebury","Connecticut","06762",{"type":84,"coordinates":134},[135,136],-73.12761,41.52787,{"lat":136,"lon":135},{"facility":139,"status":78,"city":140,"state":131,"zip":141,"country":82,"cosmosGeoPoint":142,"geoPoint":146,"contacts":11},"PACT Kidney Care","Orange","06477",{"type":84,"coordinates":143},[144,145],-73.02566,41.27843,{"lat":145,"lon":144},{"facility":148,"status":78,"city":149,"state":150,"zip":151,"country":82,"cosmosGeoPoint":152,"geoPoint":156,"contacts":11},"US Renal Care - Fort Myers South","Fort Myers","Florida","33912",{"type":84,"coordinates":153},[154,155],-81.84059,26.62168,{"lat":155,"lon":154},{"facility":158,"status":78,"city":159,"state":160,"zip":161,"country":82,"cosmosGeoPoint":162,"geoPoint":166,"contacts":11},"Nephrology & Hypertension Specialists","Dalton","Georgia","30720",{"type":84,"coordinates":163},[164,165],-84.97022,34.7698,{"lat":165,"lon":164},{"facility":168,"status":78,"city":169,"state":170,"zip":171,"country":82,"cosmosGeoPoint":172,"geoPoint":176,"contacts":11},"St. Clair Nephrology Research","Shelby","Michigan","48315",{"type":84,"coordinates":173},[174,175],-83.03298,42.67087,{"lat":175,"lon":174},{"facility":178,"status":78,"city":179,"state":180,"zip":181,"country":82,"cosmosGeoPoint":182,"geoPoint":186,"contacts":11},"DaVita Clinical Research Edina","Edina","Minnesota","55435",{"type":84,"coordinates":183},[184,185],-93.34995,44.88969,{"lat":185,"lon":184},{"facility":188,"status":78,"city":189,"state":190,"zip":191,"country":82,"cosmosGeoPoint":192,"geoPoint":196,"contacts":11},"Johnson County Clinical Trials","Kansas City","Missouri","64111",{"type":84,"coordinates":193},[194,195],-94.57857,39.09973,{"lat":195,"lon":194},{"facility":129,"status":78,"city":198,"state":199,"zip":200,"country":82,"cosmosGeoPoint":201,"geoPoint":205,"contacts":11},"Las Vegas","Nevada","89107",{"type":84,"coordinates":202},[203,204],-115.13722,36.17497,{"lat":204,"lon":203},{"facility":109,"status":78,"city":207,"state":208,"zip":209,"country":82,"cosmosGeoPoint":210,"geoPoint":214,"contacts":11},"Albuquerque","New Mexico","87109",{"type":84,"coordinates":211},[212,213],-106.65114,35.08449,{"lat":213,"lon":212},{"facility":109,"status":110,"city":216,"state":217,"zip":218,"country":82,"cosmosGeoPoint":219,"geoPoint":223,"contacts":11},"Ridgewood","New York","11385",{"type":84,"coordinates":220},[221,222],-73.90569,40.7001,{"lat":222,"lon":221},{"facility":225,"status":78,"city":226,"state":227,"zip":228,"country":82,"cosmosGeoPoint":229,"geoPoint":233,"contacts":11},"US Renal Care - Alexis","Toledo","Ohio","43613",{"type":84,"coordinates":230},[231,232],-83.55521,41.66394,{"lat":232,"lon":231},{"facility":235,"status":78,"city":236,"state":237,"zip":238,"country":82,"cosmosGeoPoint":239,"geoPoint":243,"contacts":11},"Sunbeam Research","Greenville","Texas","75402",{"type":84,"coordinates":240},[241,242],-96.11081,33.13845,{"lat":242,"lon":241},{"facility":129,"status":78,"city":245,"state":237,"zip":246,"country":82,"cosmosGeoPoint":247,"geoPoint":251,"contacts":11},"Houston","77054",{"type":84,"coordinates":248},[249,250],-95.36327,29.76328,{"lat":250,"lon":249},{"facility":253,"status":78,"city":254,"state":237,"zip":255,"country":82,"cosmosGeoPoint":256,"geoPoint":260,"contacts":11},"Gamma Medical Research","McAllen","78503",{"type":84,"coordinates":257},[258,259],-98.23001,26.20341,{"lat":259,"lon":258},{"facility":109,"status":110,"city":262,"state":237,"zip":81,"country":82,"cosmosGeoPoint":263,"geoPoint":267,"contacts":11},"San Antonio",{"type":84,"coordinates":264},[265,266],-98.49363,29.42412,{"lat":266,"lon":265},{"facility":269,"status":78,"city":262,"state":237,"zip":270,"country":82,"cosmosGeoPoint":271,"geoPoint":273,"contacts":11},"US Renal Care - Westover Hills","78251",{"type":84,"coordinates":272},[265,266],{"lat":266,"lon":265},{"facility":275,"status":78,"city":262,"state":237,"zip":276,"country":82,"cosmosGeoPoint":277,"geoPoint":279,"contacts":11},"DaVita Clinical Research San Antonio","78258",{"type":84,"coordinates":278},[265,266],{"lat":266,"lon":265},{"facility":109,"status":110,"city":281,"state":237,"zip":282,"country":82,"cosmosGeoPoint":283,"geoPoint":287,"contacts":11},"Waxahachie","75165",{"type":84,"coordinates":284},[285,286],-96.84833,32.38653,{"lat":286,"lon":285},{"facility":289,"status":78,"city":290,"state":291,"zip":292,"country":82,"cosmosGeoPoint":293,"geoPoint":297,"contacts":11},"DaVita Clinical Research Norfolk","Norfolk","Virginia","23502",{"type":84,"coordinates":294},[295,296],-76.28522,36.84681,{"lat":296,"lon":295},{"facility":109,"status":110,"city":299,"state":300,"zip":301,"country":302,"cosmosGeoPoint":303,"geoPoint":307,"contacts":11},"Beijing","Beijing Municipality","100035","China",{"type":84,"coordinates":304},[305,306],116.39723,39.9075,{"lat":306,"lon":305},{"facility":109,"status":110,"city":299,"state":300,"zip":309,"country":302,"cosmosGeoPoint":310,"geoPoint":312,"contacts":11},"100044",{"type":84,"coordinates":311},[305,306],{"lat":306,"lon":305},{"facility":109,"status":110,"city":314,"state":315,"zip":316,"country":302,"cosmosGeoPoint":317,"geoPoint":321,"contacts":11},"Zhengzhou","Henan","450003",{"type":84,"coordinates":318},[319,320],113.64861,34.75778,{"lat":320,"lon":319},{"facility":109,"status":110,"city":323,"state":324,"zip":325,"country":302,"cosmosGeoPoint":326,"geoPoint":330,"contacts":11},"Nanjing","Jiangsu","210003",{"type":84,"coordinates":327},[328,329],118.77778,32.06167,{"lat":329,"lon":328},{"facility":109,"status":110,"city":323,"state":324,"zip":332,"country":302,"cosmosGeoPoint":333,"geoPoint":335,"contacts":11},"210009",{"type":84,"coordinates":334},[328,329],{"lat":329,"lon":328},{"facility":109,"status":110,"city":337,"state":338,"zip":339,"country":302,"cosmosGeoPoint":340,"geoPoint":344,"contacts":11},"Shanghai","Shanghai Municipality","201112",{"type":84,"coordinates":341},[342,343],121.45806,31.22222,{"lat":343,"lon":342},{"facility":109,"status":110,"city":346,"state":347,"zip":348,"country":302,"cosmosGeoPoint":349,"geoPoint":353,"contacts":11},"Chengdu","Sichuan","610072",{"type":84,"coordinates":350},[351,352],104.06667,30.66667,{"lat":352,"lon":351},{"type":355,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[357],{"name":358,"class":6},"Alebund Pharmaceuticals","100053390",false,"NCT06712654","A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia","A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, and Serum Phosphate Lowering Effect of Fixed Dose AP306 in Participants With Hyperphosphatemia Receiving Maintenance Hemodialysis","Important Inclusion Criteria:\n\n* Signs a written informed consent form (ICF) and is willing to comply with all study requirements in the study\n* Receiving a stable hemodialysis (including hemodialysis, hemodiafiltration, and hemoadsorption) regimen, which is defined as a frequency of three times per week for at least 12 weeks before signing the ICF, and does not plan to change in the study\n* Who has a blood phosphate level within the study-required range\n* Who has a dialysis adequacy, assessed by single pooled Kt\u002FV (SpKt\u002FV, estimated with blood urea) ≥1.20, at screening or any documented value ≥1.20 within 12 weeks prior to signing the ICF\n* If the participant is receiving etelcalcetide, their doses must be unchanged for at least 4 weeks prior to signing the ICF\n* If the participant is receiving any of the following therapies, their doses are stable for at least 14 days prior to signing the ICF: phosphate-lowering products other than tenapanor or phosphate binders, active vitamin D and analogs, cinacalcet, calcitonin, and P-glycoprotein inhibitors\n* Agreement to use highly effective contraception for women of childbearing potentially and non-sterile sexually active males throughout the study and for 90 days after the final dose of study drug\n\nImportant Exclusion Criteria:\n\n* Pregnant or breastfeeding\n* Scheduled for a living donor kidney transplant in the next 6 months, planned change to peritoneal dialysis or home hemodialysis in the study; planned relocation to another dialysis center in the study\n* Any history of a non-pharmacological parathyroid intervention within 6 months prior to the ICF sign off, or planned parathyroid intervention in the study\n* Blood calcium or blood intact parathyroid hormone abnormality\n* Adequate organ and bone marrow function\n* Acute hepatitis or significant chronic liver disease\n* Any clinically significant GI disorders within 4 weeks prior to signing the ICF; or any history of gastrectomy; or any GI tract surgery (excluding appendectomy and polypectomy), within 12 weeks of signing the ICF\n* Uncontrolled hypertension\n* Hospitalization for cardiac or cardiocerebrovascular disease within 24 weeks prior to signing the ICF\n* Significant abnormalities of QT interval and heart rhythm on an electrocardiograph (ECG) test\n* Any clinically significant active infection or infestation or any treatment with systemic antimicrobial treatment within 2 weeks prior to signing the ICF\n* History or presence of malignancy within 3 years prior to signing the ICF, except basal cell skin cancer, in-situ carcinoma of the cervix, and in-situ prostate cancer\n* Taking moderate or strong cytochrome P450 (CYP) 3A inhibitors within 2 weeks or 5 half-lives, whichever is longer, prior to signing the ICF (topical use is allowed)\n* Treatment with any investigational medication or medical device within 30 days prior to signing the ICF\n* Life expectancy less than 12 months","ALL","18 Years",{"count":368,"type":369},168,"ESTIMATED","INTERVENTIONAL",[372],"PHASE2","This study is being conducted to characterize the safety, tolerability, and efficacy of AP306 at fixed doses in adults with hyperphosphatemia receiving maintenance hemodialysis.",[375,376,377],"Hyperphosphatemia","Chronic Kidney Disease Requiring Chronic Dialysis","End Stage Renal Disease on Dialysis",[379,380,381,382],"AP306","AP-306","EOS789","pan-phosphate transporter inhibitor","2026-07-10",{"date":385,"type":386},"2026-07-13","ACTUAL",{"date":388,"type":386},"2026-06-01",{"date":390,"type":369},"2027-03-31",{"name":5,"class":6},31]